Return to Listing

1 result(s) for

PI Name Protocol # Title
Rachel Cook STUDY00015953 A Biomarker-Directed Phase 2 Trial of SY-1425, a Selective Retinoic Acid Receptor Alpha Agonist, in Adult Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080